In a significant move aimed at strengthening drug regulation and preventing misuse of medicines, the Indian government has decided to make prescriptions mandatory for the purchase of codeine-based cough syrups. The decision effectively ends the sale of such medicines through over-the-counter (OTC) channels and eliminates the practice of purchasing them online using only one-time password (OTP) verification.
The policy shift comes amid growing concerns over the misuse and abuse of codeine-containing formulations, particularly among young users and vulnerable populations. Health authorities believe that tighter control over the sale and distribution of these medicines will help curb addiction, illegal diversion, and unauthorized consumption.
End of OTC and OTP-Based Sales
Until now, certain online pharmacies and retail outlets allowed customers to purchase regulated cough syrups through simplified verification methods, including OTP authentication. Under the revised framework, such medicines can only be dispensed upon presentation of a valid prescription issued by a registered medical practitioner.
The change is expected to bring greater accountability to the sale of controlled medicines and ensure that these products are used strictly for legitimate medical purposes.
Officials have indicated that the new rules will apply across both physical pharmacies and digital medicine platforms, creating a uniform regulatory environment for prescription drugs. 
Why the Government Took This Step
Codeine is an opioid-derived substance commonly used in cough syrups because of its effectiveness in suppressing persistent coughs. However, medical experts have repeatedly warned that prolonged or unsupervised consumption can lead to dependency, addiction, and other serious health complications.
Authorities have expressed concern that easy access to codeine-based medicines has contributed to their misuse in several parts of the country. Reports of recreational consumption and unauthorized distribution have prompted regulators to strengthen monitoring mechanisms and close loopholes that allowed easier access.
By requiring a doctor’s prescription, the government aims to ensure that patients receive proper medical evaluation before using such medicines.
Public Health and Safety at the Core
Health experts have largely welcomed the decision, arguing that stronger controls are necessary to prevent the misuse of opioid-based medications. Medical professionals believe that requiring prescriptions will encourage responsible use and reduce the risks associated with self-medication.
The move also aligns with broader efforts to promote rational drug use and enhance patient safety. Regulators have emphasized that medicines with abuse potential should remain under strict medical supervision to minimize health risks.
In addition, authorities expect the measure to improve tracking of prescription drug sales, making it easier to identify unusual purchasing patterns and potential cases of diversion into illegal markets. ![]()
Impact on Online Pharmacies
The decision is likely to have a significant impact on online medicine delivery platforms. These companies will now be required to implement stricter verification procedures and ensure that customers upload valid prescriptions before completing purchases of regulated cough syrups.
Industry stakeholders are expected to adjust their compliance systems to meet the revised requirements. While the transition may initially increase administrative checks, policymakers believe it will strengthen consumer protection and regulatory oversight in the long term.
Balancing Accessibility and Regulation
Government officials have clarified that the objective is not to restrict access for genuine patients but to ensure that medicines with addiction potential are dispensed responsibly. Patients with legitimate medical needs will continue to receive treatment through prescriptions issued by qualified healthcare professionals.
The new framework seeks to strike a balance between accessibility and safety by ensuring that effective cough treatments remain available while reducing opportunities for misuse.
Strengthening the Fight Against Drug Abuse
The prescription requirement forms part of a broader effort to tackle drug abuse and improve pharmaceutical governance. By tightening controls on codeine-based cough syrups, authorities hope to reduce unauthorized consumption, protect public health, and reinforce confidence in the country’s healthcare regulatory system.
The move marks an important step toward ensuring that medicines with potential for abuse are used only under appropriate medical guidance, reflecting a growing emphasis on patient safety and responsible healthcare practices.
